Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secondary IgA nephropathy.

Shideh Pouria1, Jonathan Barratt

  • 1Renal Unit, New Guy's House, Guy's Hospital, London, United Kingdom.

Seminars in Nephrology
|January 29, 2008
PubMed
Summary
This summary is machine-generated.

IgA nephropathy (IgAN), a common kidney disease, may be triggered by environmental factors like diet and microbes. Research explores potential links between IgAN and other conditions, suggesting shared underlying causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring effectiveness in immunoglobulin A nephropathy: what are we looking for?

Clinical kidney journal·2026
Same author

Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.

JAMA·2026
Same author

Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

Zigakibart Potently Inhibits A Proliferation-Inducing Ligand-Mediated IgA Production, Addressing IgAN Pathogenesis Root Causes.

Kidney international reports·2026
Same author

Simultaneous or Sequential Treatment of IgA Nephropathy - Specific Disease Drivers and Non-specific Consequences of Nephron Loss?

Clinical kidney journal·2026
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Area of Science:

  • Nephrology
  • Immunology
  • Gastroenterology

Background:

  • IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis in Western countries.
  • The etiology of IgAN is often unknown, but familial and secondary forms offer clues.
  • Secondary IgAN is frequently associated with liver disease or mucosal inflammation, particularly in the gut.

Purpose of the Study:

  • To explore the role of environmental factors in IgA nephropathy pathogenesis.
  • To investigate potential triggers such as dietary and microbial antigens.
  • To discuss reported associations between IgAN and other diseases.

Main Methods:

  • Review of existing literature on IgA nephropathy.
  • Identification of dietary and microbial antigens in IgA deposits.

Related Experiment Videos

  • Analysis of reported associations with other medical conditions.

    • Main Results:

    • Dietary and microbial antigens are found in IgA immune complexes and kidney deposits.
    • Environmental factors are implicated in the development of IgAN.
    • Numerous associations between IgAN and other diseases are documented in literature.

    Conclusions:

    • Environmental factors, including antigens from diet and microbes, likely contribute to IgAN.
    • Further research is needed to determine if reported IgAN associations indicate shared pathophysiology or chance.
    • Understanding triggers is crucial for managing this common glomerular disease.